Newsroom

For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

Mutant mice resist addictive effects of cocaine in new study Feb 13, 2017

A team of researchers has genetically engineered a mouse that does not become addicted to cocaine, adding to the evidence that genetics and biochemistry play a significant role in drug addiction. The researchers, led by Dr. Shernaz Bamji, were able to reduce behaviours associated with cocaine addiction by regulating the effect of the drug on the synpases, preventing the drug from making lasting changes to the brain.

+
Dr. Cheryl Wellington is paving the way in Alzheimer’s research Jan 31, 2017

January is Alzheimer’s Awareness Month. Dr. Cheryl Wellington, a Professor in the Department of Pathology and Laboratory Medicine, has devoted her career to understanding the genetic and environmental risk factors that affect dementia. Her discovery of the role that apolipoprotein (ApoE) – a cholesterol carrier in the brain – plays in Alzheimer’s is internationally recognized and has offered us a better understanding of the disease.

+
Roots of Alzheimer’s disease can extend as far back as the womb Jan 27, 2017

The biochemical reactions that cause Alzheimer’s disease could be set in motion in the womb or just after birth if the fetus or newborn does not get enough Vitamin A, according to new research from the Djavad Mowafaghian Centre for Brain Health at the University of British Columbia.

Although it has long been known that Alzheimer’s disease unfolds in a person’s brain decades before symptoms appear, this is the first time the roots of the disease have been traced back to infancy or pre-natal development.

+
New Initiative Gives Clinicians a Voice Jan 19, 2017

A new physician-engagement initiative is coming to UBC Hospital and the Djavad Mowafaghian Centre for Brain Health.

The initiative’s goal is to involve physicians working in acute care facilities as true partners in the healthcare decision-making process, and help generate improvements that will make our future BC healthcare system sustainable. Without involving physicians, achieving better patient care, and better community health at the lowest cost possible will remain elusive goals.

+
DMCBH members appointed to BC Leadership Chairs Jan 19, 2017

Two researchers affiliated with the Djavad Mowafaghian Centre for Brain Health – Dr. Michael Kobor and Dr. Raymond Lam – have been appointed BC Leadership Chairs, a program aimed at fostering world-class research in British Columbia.

+
National study paints detailed picture of aging in Canada Jan 18, 2017

On the first floor of the Djavad Mowafaghian Centre for Brain Health, a massive, two decade-long project has been quietly underway for the past three years. The Vancouver Data Collection Site for the Canadian Longitudinal Study on Aging (CLSA) is based here, and Dr. Heather Stewart and her team are returning to the Centre to start the first follow-up after 18 months collecting data at SFU Surrey’s CLSA data collection site.

+
Member news: January 2017 Jan 17, 2017

Links to stories about and by members of the Djavad Mowafaghian Centre for Brain Health from December 2016/January 2017.

+
Study finds increased healthcare system use related to infections in people with MS Jan 11, 2017

New research from MSFHR trainee Jose Wijnands (PI: Dr. Helen Tremlett) fills knowledge gaps and establishes a baseline for understanding infection risk for people with multiple sclerosis (MS) relative to those without MS.

+
Recapping the 2016 Neuroscience Extravaganza Jan 5, 2017

The event was well-attended, with as many as 80 people, including faculty, postdocs and graduate students, participating in the presentations and judging. 

+
Study of exercise and Parkinson’s disease yields positive results Jan 4, 2017

Habitual exercise may confer an advantage in combating Parkinson’s disease by facilitating the brain’s production of a crucial neurochemical, according to preliminary findings from a UBC study.

+

Pages